Last reviewed · How we verify

NCT05404477: ERAS

Study of TransAeris® System for Enhanced Recovery After Surgery in France

Completed NA Last updated 12 November 2024
What this trial tests

NA trial testing TransAeris System in Ventilator-Induced Diaphragm Dysfunction in 30 participants. Completed in 17 August 2023.

Timeline
22 June 2022
Primary endpoint
13 July 2023
17 August 2023

Quick facts

Lead sponsorSynapse Biomedical
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposetreatment
Enrollment30
Start date22 June 2022
Primary completion13 July 2023
Estimated completion17 August 2023
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Synapse Biomedical

Who can join

22 and older, any sex, with Ventilator-Induced Diaphragm Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be conducted as a randomized trial of the TransAeris system for the prevention and treatment of ventilator-induced diaphragm dysfunction (VIDD) in patients identified prior to surgery to be at greater risk of prolonged mechanical ventilation (PMV).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Multicentre Study of Diaphragm Pacing in High-Risk Cardiac Surgery to Decrease Postoperative Mechanical Ventilation.
    David CH, Vourc'h M, Guimbretiere G, Mugniot A, et al · · 2026 · PMID 41416899 · DOI 10.1093/ejcts/ezaf472

Verify or expand the search:

Other trials of TransAeris System

Trials testing the same drug.

Other Synapse Biomedical trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05404477.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing